Anti-Doping Agency (USADA). It falls under Category S2: Peptide Hormones, Growth Factors, Related Substances, and Mimetics on the WADA Prohibited List, often specified as a "Growth Hormone Releasing Hormone (GHRH) and its analogues" or a "Growth Hormone Secretagogue (GHS)". The ban is due to its potential to unfairly enhance athletic performance by increasing muscle mass, strength, reducing fat, and improving recovery. The prohibition applies regardless of its mechanism of stimulating endogenous GH, as the outcome of artificially elevated GH/IGF-1 is the concern
Plan design can vary by employer, particularly when a BCBS company administers a self-funded plan
It retains the core amylin sequence but incorporates lipidation and amino acid substitutions that extend half-life and receptor affinity
GHK-Cu is the best starting point if barrier dysfunction dominates your presentation
Never start Wegovy without medical supervision , particularly if you have any thyroid-related concerns or a complex medical history
Retatrutide 12 mg produced 24.2% mean body-weight loss at 48 weeks in the Phase 2 obesity trial (Jastreboff et al., NEJM 2023) [3][4]